Lv1
60 积分 2024-07-21 加入
Integrated genomic characterization of endometrial carcinoma
1个月前
已完结
ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix
1个月前
已完结
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update
1个月前
已关闭
ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology—Gynecology
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
4个月前
已完结
Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance
4个月前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
4个月前
已完结
皖公网安备34019202002308
